Fourteen Panel Drug Test Cup with ETG and Fentanyl (FUO)

Fourteen Panel Drug Test Cup with ETG and Fentanyl (FUO)

COVID-19 Rapid Antigen Test

Celltrion DiaTrust™ COVID-19 Ag Rapid Test is a rapid test based on lateral flow immunoassay intended for the qualitative detection of nucleocapsid and receptor binding domains (RBDs) from the SARS-CoV-2 spike proteins in human nasopharyngeal swab specimen. Results are for the identification of SARS-CoV-2 nucleocapsid and RBD protein antigen.

 

Included in each box:

  • 25 test devices

  • 25 swabs

  • 25 extraction buffer

  • filter caps

  • 1 positive control swab

  • 1 negative control swab

  • 1 Quick Reference Instruction

Availability: In stock

Buy more, save more!

only $225.00 when you buy 41 cases or more.

Product sold in cases of 25 tests
1-45-1213-2021-4041+
$325.00$287.50$250.00$237.50$225.00
$13.00 each$11.50 each$10.00 each$9.50 each$9.00 each
*Discounts may vary based on options above
  • Buy 5 for $287.50 each and save 12%
  • Buy 13 for $250.00 each and save 23%
  • Buy 21 for $237.50 each and save 27%
  • Buy 41 for $225.00 each and save 31%

You've just added this product to the cart:

COVID-19 Rapid Antigen Test

  • For use under Emergency Use Authorization Only.

  • For in vitro diagnostic use only.

  • For prescription use only.

  • Read all instructions completely and carefully and follow all instructions. Failure to follow all instructions may result in inaccurate test results.

  • This product has not been FDA cleared or approved, but has been authorized by FDA under an Emergency Use Authorization (EUA) for use by laboratories certified under the CLIA that meet the requirements to perform high or moderate complexity, or waived tests.

  • This product is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.

  • This product has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens

  • The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or the authorization is revoked sooner.